SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-212691
Filing Date
2015-06-04
Accepted
2015-06-04 09:07:53
Documents
5
Period of Report
2015-07-07
Effectiveness Date
2015-06-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d861971ddef14a.htm DEF 14A 514894
2 GRAPHIC g861971g00a80.jpg GRAPHIC 7752
3 GRAPHIC g861971g09k10.jpg GRAPHIC 6741
4 GRAPHIC g861971g32i96.jpg GRAPHIC 29583
5 GRAPHIC g861971g75d29.jpg GRAPHIC 43130
  Complete submission text file 0001193125-15-212691.txt   636788
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10352 | Film No.: 15911952
SIC: 2834 Pharmaceutical Preparations